COPD maintenance medication is linked to left atrial size: results from the COSYCONET cohort

Background - Lung function impairment in COPD is known to be related to reductions of left heart size, while short-term interventional trials with bronchodilators showed positive effects on cardiac parameters. We investigated whether COPD maintenance therapy has analogous long-term effects. - Method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kellerer, Christina (VerfasserIn) , Kahnert, Kathrin (VerfasserIn) , Trudzinski, Franziska (VerfasserIn) , Lutter, Johanna I. (VerfasserIn) , Berschneider, Korbinian (VerfasserIn) , Speicher, Tim (VerfasserIn) , Watz, Henrik (VerfasserIn) , Bals, Robert (VerfasserIn) , Welte, Tobias (VerfasserIn) , Vogelmeier, Claus F. (VerfasserIn) , Jörres, Rudolf A. (VerfasserIn) , Alter, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 May 2021
In: Respiratory medicine
Year: 2021, Jahrgang: 185, Pages: 1-7
ISSN:1532-3064
DOI:10.1016/j.rmed.2021.106461
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.rmed.2021.106461
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0954611121001670
Volltext
Verfasserangaben:Christina Kellerer, Kathrin Kahnert, Franziska C. Trudzinski, Johanna Lutter, Korbinian Berschneider, Tim Speicher, Henrik Watz, Robert Bals, Tobias Welte, Claus F. Vogelmeier, Rudolf A. Jörres, Peter Alter

MARC

LEADER 00000caa a2200000 c 4500
001 177570534X
003 DE-627
005 20240414193528.0
007 cr uuu---uuuuu
008 211029s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.rmed.2021.106461  |2 doi 
035 |a (DE-627)177570534X 
035 |a (DE-599)KXP177570534X 
035 |a (OCoLC)1341422449 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kellerer, Christina  |e VerfasserIn  |0 (DE-588)1244242071  |0 (DE-627)1775328341  |4 aut 
245 1 0 |a COPD maintenance medication is linked to left atrial size  |b results from the COSYCONET cohort  |c Christina Kellerer, Kathrin Kahnert, Franziska C. Trudzinski, Johanna Lutter, Korbinian Berschneider, Tim Speicher, Henrik Watz, Robert Bals, Tobias Welte, Claus F. Vogelmeier, Rudolf A. Jörres, Peter Alter 
264 1 |c 29 May 2021 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.10.2021 
520 |a Background - Lung function impairment in COPD is known to be related to reductions of left heart size, while short-term interventional trials with bronchodilators showed positive effects on cardiac parameters. We investigated whether COPD maintenance therapy has analogous long-term effects. - Methods - Pooled data of GOLD grade 1-4 patients from visits 1 and 3 (1.5 y apart) of the COSYCONET cohort were used. Medication was categorized as use of ICS, LABA + ICS, LABA + LAMA and triple therapy (LABA + LAMA + ICS), contrasting “always” versus “never”. Echocardiographic parameters comprised left ventricular end-diastolic and -systolic diameter (LVEDD, LVESD), ejection fraction (LVEF) and left atrial diameter (LA). Associations were identified by multiple regression analysis, as well as propensity score analysis. - Results - Overall, 846 patients (mean age 64.5 y; 41% female) were included, 53% using ICS at both visits, 51% LABA + ICS, 56% LABA + LAMA, 40% LABA + LAMA + ICS (triple) therapy. Conversely, 30%, 32%, 28% and 42% had no ICS, LABA + ICS, LABA + LAMA or triple therapy, respectively, at both visits. Among echocardiographic measures, only LA showed statistically significant associations (increases) with medication, whereby significant effects were linked to ICS, LABA + ICS and LABA + LAMA (p < 0.05 each, “always” versus “never”) and propensity score analyses underlined the role of LABA + LAMA. - Conclusions - In this observational study, COPD maintenance therapy, especially LABA + LAMA, was linked to left atrial size, consistent with the results of short-term interventional trials. These findings suggest that maintenance medication for COPD does not only improve lung function and patient reported outcomes but may also have an impact on the cardiovascular system. - Trial registration - NCT01245933 
650 4 |a Cardiac size 
650 4 |a COPD 
650 4 |a ICS 
650 4 |a LABA 
650 4 |a LAMA 
650 4 |a Left atrium 
650 4 |a Maintenance medication 
700 1 |a Kahnert, Kathrin  |d 1985-  |e VerfasserIn  |0 (DE-588)1014951178  |0 (DE-627)705309681  |0 (DE-576)349886210  |4 aut 
700 1 |a Trudzinski, Franziska  |d 1976-  |e VerfasserIn  |0 (DE-588)1145072836  |0 (DE-627)100530047X  |0 (DE-576)495615579  |4 aut 
700 1 |a Lutter, Johanna I.  |d 1993-  |e VerfasserIn  |0 (DE-588)1225422418  |0 (DE-627)1745063129  |4 aut 
700 1 |a Berschneider, Korbinian  |e VerfasserIn  |4 aut 
700 1 |a Speicher, Tim  |e VerfasserIn  |4 aut 
700 1 |a Watz, Henrik  |d 1971-  |e VerfasserIn  |0 (DE-588)124250815  |0 (DE-627)085737321  |0 (DE-576)294088156  |4 aut 
700 1 |a Bals, Robert  |d 1968-  |e VerfasserIn  |0 (DE-588)122466349  |0 (DE-627)081961030  |0 (DE-576)293284369  |4 aut 
700 1 |a Welte, Tobias  |d 1959-2024  |e VerfasserIn  |0 (DE-588)133584682  |0 (DE-627)548438641  |0 (DE-576)186295987  |4 aut 
700 1 |a Vogelmeier, Claus F.  |e VerfasserIn  |0 (DE-588)142839213  |0 (DE-627)640541291  |0 (DE-576)333646967  |4 aut 
700 1 |a Jörres, Rudolf A.  |e VerfasserIn  |4 aut 
700 1 |a Alter, Peter  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Respiratory medicine  |d Burlington, Mass. : Harcourt, 1999  |g 185(2021), Artikel-ID 106461, Seite 1-7  |h Online-Ressource  |w (DE-627)320420973  |w (DE-600)2002557-9  |w (DE-576)103746870  |x 1532-3064  |7 nnas  |a COPD maintenance medication is linked to left atrial size results from the COSYCONET cohort 
773 1 8 |g volume:185  |g year:2021  |g elocationid:106461  |g pages:1-7  |g extent:7  |a COPD maintenance medication is linked to left atrial size results from the COSYCONET cohort 
856 4 0 |u https://doi.org/10.1016/j.rmed.2021.106461  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0954611121001670  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211029 
993 |a Article 
994 |a 2021 
998 |g 1145072836  |a Trudzinski, Franziska  |m 1145072836:Trudzinski, Franziska  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1145072836  |e 950000PT1145072836  |e 950900PT1145072836  |e 50000PT1145072836  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 3 
999 |a KXP-PPN177570534X  |e 3997227195 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Christina Kellerer, Kathrin Kahnert, Franziska C. Trudzinski, Johanna Lutter, Korbinian Berschneider, Tim Speicher, Henrik Watz, Robert Bals, Tobias Welte, Claus F. Vogelmeier, Rudolf A. Jörres, Peter Alter"]},"language":["eng"],"note":["Gesehen am 29.10.2021"],"recId":"177570534X","person":[{"role":"aut","family":"Kellerer","display":"Kellerer, Christina","given":"Christina"},{"family":"Kahnert","role":"aut","given":"Kathrin","display":"Kahnert, Kathrin"},{"given":"Franziska","display":"Trudzinski, Franziska","role":"aut","family":"Trudzinski"},{"role":"aut","family":"Lutter","given":"Johanna I.","display":"Lutter, Johanna I."},{"role":"aut","family":"Berschneider","display":"Berschneider, Korbinian","given":"Korbinian"},{"family":"Speicher","role":"aut","display":"Speicher, Tim","given":"Tim"},{"given":"Henrik","display":"Watz, Henrik","family":"Watz","role":"aut"},{"display":"Bals, Robert","given":"Robert","family":"Bals","role":"aut"},{"family":"Welte","role":"aut","given":"Tobias","display":"Welte, Tobias"},{"given":"Claus F.","display":"Vogelmeier, Claus F.","role":"aut","family":"Vogelmeier"},{"family":"Jörres","role":"aut","given":"Rudolf A.","display":"Jörres, Rudolf A."},{"display":"Alter, Peter","given":"Peter","role":"aut","family":"Alter"}],"id":{"eki":["177570534X"],"doi":["10.1016/j.rmed.2021.106461"]},"physDesc":[{"extent":"7 S."}],"title":[{"title_sort":"COPD maintenance medication is linked to left atrial size","title":"COPD maintenance medication is linked to left atrial size","subtitle":"results from the COSYCONET cohort"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"29 May 2021"}],"relHost":[{"recId":"320420973","origin":[{"publisherPlace":"Burlington, Mass.","dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisher":"Harcourt"}],"id":{"eki":["320420973"],"issn":["1532-3064"],"zdb":["2002557-9"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Respiratory medicine","title_sort":"Respiratory medicine"}],"note":["Gesehen am 21.02.20"],"pubHistory":["83.1989 -"],"part":{"text":"185(2021), Artikel-ID 106461, Seite 1-7","extent":"7","pages":"1-7","year":"2021","volume":"185"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"COPD maintenance medication is linked to left atrial size results from the COSYCONET cohortRespiratory medicine"}]} 
SRT |a KELLERERCHCOPDMAINTE2920